303 related articles for article (PubMed ID: 25023849)
21. [Current therapeutic strategies for mantle cell lymphoma].
Dreyling M; Schnaiter A; Schmidt C; Hoster E
Internist (Berl); 2016 Mar; 57(3):230-7. PubMed ID: 26886710
[TBL] [Abstract][Full Text] [Related]
22. The role of targeted treatment in mantle cell lymphoma: is transplant dead or alive?
Dreyling M; Ferrero S;
Haematologica; 2016 Feb; 101(2):104-14. PubMed ID: 26830211
[TBL] [Abstract][Full Text] [Related]
23. Integrating emerging treatment options in mantle cell lymphoma.
Kahl BS; Fowler NH; Czuczman MS
Clin Adv Hematol Oncol; 2013 Dec; 11(12 Suppl 19):1-15. PubMed ID: 24893155
[TBL] [Abstract][Full Text] [Related]
24. Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents.
Inamdar AA; Goy A; Ayoub NM; Attia C; Oton L; Taruvai V; Costales M; Lin YT; Pecora A; Suh KS
Oncotarget; 2016 Jul; 7(30):48692-48731. PubMed ID: 27119356
[TBL] [Abstract][Full Text] [Related]
25. Advances and issues in mantle cell lymphoma research: report of the 2014 Mantle Cell Lymphoma Consortium Workshop.
Kahl BS; Gordon LI; Dreyling M; Gascoyne RD; Sotomayor EM
Leuk Lymphoma; 2015; 56(9):2505-11. PubMed ID: 25944379
[TBL] [Abstract][Full Text] [Related]
26. R-CHOP or R-HyperCVAD with or without autologous stem cell transplantation for older patients with mantle cell lymphoma.
Frosch Z; Luskin MR; Landsburg DJ; Schuster SJ; Svoboda J; Loren AW; Porter DL; Stadtmauer EA; Nasta SD
Clin Lymphoma Myeloma Leuk; 2015 Feb; 15(2):92-7. PubMed ID: 25174772
[TBL] [Abstract][Full Text] [Related]
27. The current therapeutic scenario for relapsed mantle cell lymphoma.
Ferrero S; Dreyling M
Curr Opin Oncol; 2013 Sep; 25(5):452-62. PubMed ID: 23872784
[TBL] [Abstract][Full Text] [Related]
28. Management of mantle cell lymphoma: key challenges and next steps.
Williams ME; Dreyling M; Winter J; Muneer S; Leonard JP
Clin Lymphoma Myeloma Leuk; 2010 Oct; 10(5):336-46. PubMed ID: 21030346
[TBL] [Abstract][Full Text] [Related]
29. Novel targeted therapeutics for mantle cell lymphoma--what's on the horizon?
El Halabi L; Ghez D; Ribrag V
Expert Rev Hematol; 2016 Mar; 9(3):271-81. PubMed ID: 26689790
[TBL] [Abstract][Full Text] [Related]
30. [Salvage therapy in relapsed or refractory malignant lymphoma].
Kashimura T; Murohashi I
Nihon Rinsho; 2000 Mar; 58(3):699-703. PubMed ID: 10741149
[TBL] [Abstract][Full Text] [Related]
31. New strategies in the treatment of mantle cell lymphoma.
Deng C; Lee S; O'Connor OA
Clin Cancer Res; 2012 Jul; 18(13):3499-508. PubMed ID: 22700864
[TBL] [Abstract][Full Text] [Related]
32. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma.
Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS
Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245
[TBL] [Abstract][Full Text] [Related]
33. Update on mantle cell lymphoma.
Maddocks K
Blood; 2018 Oct; 132(16):1647-1656. PubMed ID: 30154113
[TBL] [Abstract][Full Text] [Related]
34. Mantle Cell Lymphoma: Current and Emerging Treatment Strategies and Unanswered Questions.
Diamond B; Kumar A
Hematol Oncol Clin North Am; 2019 Aug; 33(4):613-626. PubMed ID: 31229158
[TBL] [Abstract][Full Text] [Related]
35. Should there be a standard therapy for mantle cell lymphoma?
Smith MR
Future Oncol; 2011 Feb; 7(2):227-37. PubMed ID: 21345142
[TBL] [Abstract][Full Text] [Related]
36. Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphoma.
William BM; Allen MS; Loberiza FR; Bociek RG; Bierman PJ; Armitage JO; Vose JM
Biol Blood Marrow Transplant; 2014 Apr; 20(4):536-42. PubMed ID: 24434781
[TBL] [Abstract][Full Text] [Related]
37. Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur.
Geisler CH; Kolstad A; Laurell A; Jerkeman M; Räty R; Andersen NS; Pedersen LB; Eriksson M; Nordström M; Kimby E; Bentzen H; Kuittinen O; Lauritzsen GF; Nilsson-Ehle H; Ralfkiaer E; Ehinger M; Sundström C; Delabie J; Karjalainen-Lindsberg ML; Brown P; Elonen E;
Br J Haematol; 2012 Aug; 158(3):355-62. PubMed ID: 22640180
[TBL] [Abstract][Full Text] [Related]
38. Autologous transplantation and management of younger patients with mantle cell lymphoma.
Geisler CH
Best Pract Res Clin Haematol; 2012 Jun; 25(2):211-20. PubMed ID: 22687457
[TBL] [Abstract][Full Text] [Related]
39. [Current strategies in the treatment of advanced stage mantle cell lymphoma].
Lenz G; Dreyling M; Unterhalt M; Hiddemann W
Dtsch Med Wochenschr; 2004 Nov; 129(45):2429-33. PubMed ID: 15529247
[TBL] [Abstract][Full Text] [Related]
40. Autologous Stem Cell Transplant: Still the Standard for Fit Patients With Mantle Cell Lymphoma.
Staton AD; Langston AA
Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S96-S99. PubMed ID: 28760309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]